Competitive Cancer Vaccine technology

 

Our Vaccines induce the highest levels of immune response (CD4+ , CD8+, antibodies, innate immunity)

 

Adenoviral vectors

  • Superiority to other genetic vectors (DNA and viral)
  • Lower prevalence Ad serotypes


Muscle Electro-gene-transfer

  • Unlimited potential
  • Pioneering work of our group in the field

Design Protein/Peptide vaccines

  • Modifications with enhanced immunogenicity

Takis Biotech

Takis Services